Skip to main content

Advertisement

SpringerLink
Log in

Leptin-induced signaling pathways in cancer cell migration and invasion

  • Review
  • Published:
Cellular Oncology Aims and scope Submit manuscript

Abstract

Background

Increasing evidence indicates that obesity is associated with tumor development and progression. Leptin is an adipocyte-related hormone with a key role in energy metabolism and whose circulating levels are elevated in obesity. The effect of leptin on cancer progression and metastasis and its underlying mechanisms are still unclear. Leptin can impact various steps in tumor metastasis, including epithelial-mesenchymal transition, cell adhesion to the extracellular matrix (ECM), and proteolysis of ECM components. To do so, leptin binds to its receptor (OB-Rb) to activate signaling pathways and downstream effectors that participate in tumor cell invasion as well as distant metastasis.

Conclusions

In this review, we describe metastasis steps in detail and characterize metastasis-related molecules activated by leptin, which may help to develop a roadmap that guides future work. In addition, we conclude that a profound understanding of the fundamental molecular processes that contribute to leptin-induced metastasis may pave the way for the development of new prognostic molecules and appropriate approaches to the treatment of obesity-related cancers.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1

Similar content being viewed by others

References

  1. I. Vucenik, J.P. Stains, Obesity and cancer risk: evidence, mechanisms, and recommendations. Ann. N. Y. Acad. Sci. 1271, 37–43 (2012)

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  2. E.-J. Choi, H.-R. Kim, J.-H. Kie, B.-I. Moon and J.-Y. Seoh, Attenuation of obesity and related metabolic disorders by the individual or combination treatment with IL-2/anti-IL-2 complex and hyperbaric oxygen. bioRxiv. 351841 (2018)

  3. M.I. Goran, G.D. Ball, M.L. Cruz, Obesity and risk of type 2 diabetes and cardiovascular disease in children and adolescents. J. Clin. Endocrinol. Metab. 88, 1417–1427 (2003)

    Article  CAS  PubMed  Google Scholar 

  4. A. Khodabakhshi, M. Ghayour-Mobarhan, H. Rooki, R. Vakili, S. Hashemy, S. Mirhafez, M. Shakeri, R. Kashanifar, R. Pourbafarani, H. Mirzaei, Comparative measurement of ghrelin, leptin, adiponectin, EGF and IGF-1 in breast milk of mothers with overweight/obese and normal-weight infants. Eur. J. Clin. Nutr. 69, 614–618 (2015)

    Article  CAS  PubMed  Google Scholar 

  5. L. Mazzarella, Why does obesity promote cancer? Ecancermedicalscience 9, 554 (2015)

    Article  PubMed  PubMed Central  Google Scholar 

  6. J. Ferlay, I. Soerjomataram, R. Dikshit, S. Eser, C. Mathers, M. Rebelo, D.M. Parkin, D. Forman, F. Bray, Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012. Int. J. Cancer 136, E359–386 (2015)

    Article  CAS  PubMed  Google Scholar 

  7. G.A. Colditz, L.L. Peterson, Obesity and cancer: evidence, impact, and future directions. Clin. Chem. Clinchem. 64, 154–162 (2018)

    Article  CAS  Google Scholar 

  8. X. Fang, J. Wei, X. He, J. Lian, D. Han, P. An, T. Zhou, S. Liu, F. Wang, J. Min, Q uantitative association between body mass index and the risk of cancer: A global meta-analysis of prospective cohort studies. Int. J. Cancer 143, 1595–1603 (2018)

    Article  CAS  PubMed  Google Scholar 

  9. M.A. Lichtman, Obesity and the risk for a hematological malignancy: leukemia, lymphoma, or myeloma. The Oncologist 15, 1083–1101 (2010)

    Article  PubMed  PubMed Central  Google Scholar 

  10. S. Ladhani, B. Empringham, K.-W. Wang, C. Portwine, L. Banfield, R.J. de Souza, L. Thabane, M.C. Samaan, Overweight and obesity management strategies in survivors of paediatric acute lymphoblastic leukaemia: a systematic review protocol. BMJ Open 8, e022530 (2018)

  11. A. Tarasiuk, P. Mosińska, J. Fichna, The mechanisms linking obesity to colon cancer: an overview. Obes. Res. Clin. Pract. 12, 251–259 (2018)

    Article  PubMed  Google Scholar 

  12. S.G. Krishna, H. Hussan, Z. Cruz-Monserrate, L.F. Conteh, K. Mumtaz, D.L. Conwell, A review of the impact of obesity on common gastrointestinal malignancies. Integr. Cancer Sci. Ther. 4 (2017). https://doi.org/10.15761/ICST.1000223

  13. P. Gild, B. Ehdaie, L.A. Kluth, Effect of obesity on bladder cancer and renal cell carcinoma incidence and survival. Curr. Opin. Urol. 27, 409–414 (2017)

    Article  PubMed  Google Scholar 

  14. D. Sharma, N. Saxena, P. Vertino, F. Anania, Leptin promotes the proliferative response and invasiveness in human endometrial cancer cells by activating multiple signal-transduction pathways. Endocr. Relat. Cancer 13, 629–640 (2006)

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  15. S. Kitson, J. Duffy, N. Ryan, M. MacKintosh, E. Crosbie, Interventions for weight reduction in obesity to improve survival in women with endometrial cancer. Cochrane Database Syst. Rev. (2018). https://doi.org/10.1002/14651858.CD012513.pub2

  16. I. Huang-Doran, S. Franks, Genetic rodent models of obesity-associated ovarian dysfunction and subfertility: insights into polycystic ovary syndrome. Front. Endocrinol. 7, 53 (2016). https://doi.org/10.3389/fendo.2016.00053

    Article  Google Scholar 

  17. L. Gan, Z. Liu, C. Sun, Obesity linking to hepatocellular carcinoma: A global view. Biochim. Biophys. Acta Rev. Cancer 1869, 97–102 (2018)

    Article  CAS  PubMed  Google Scholar 

  18. D. Li, J.S. Morris, J. Liu, M.M. Hassan, R.S. Day, M.L. Bondy, J.L. Abbruzzese, Body mass index and risk, age of onset, and survival in patients with pancreatic cancer. JAMA. 301, 2553–2562 (2009)

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  19. M. Xu, X. Jung, O.J. Hines, G. Eibl, Y. Chen, Obesity and pancreatic cancer: overview of epidemiology and potential prevention by weight loss. Pancreas 47, 158–162 (2018)

    Article  PubMed  PubMed Central  Google Scholar 

  20. R.J. MacInnis, D.R. English, Body size and composition and prostate cancer risk: systematic review and meta-regression analysis. Cancer Causes Control. 17, 989–1003 (2006)

    Article  PubMed  Google Scholar 

  21. M. Bandini, G. Gandaglia, A. Briganti, Obesity and prostate cancer. Curr. Opin. Urol. 27, 415–421 (2017)

    Article  PubMed  Google Scholar 

  22. E.H.B.C.C. Group, Body mass index, serum sex hormones, and breast cancer risk in postmenopausal women. J. Natl. Cancer Inst. 95, 1218–1226 (2003)

  23. Y. Geng, J. Wang, R. Wang, K. Wang, Y. Xu, G. Song, C. Wu, Y. Yin, Leptin and HER-2 are associated with gastric cancer progression and prognosis of patients. Biomed. Pharmacother. 66, 419–424 (2012)

    Article  CAS  PubMed  Google Scholar 

  24. S. Mahbouli, A. Der Vartanian, S. Ortega, S. Rougé, M.-P. Vasson, A. Rossary, Leptin induces ROS via NOX5 in healthy and neoplastic mammary epithelial cells. Oncol. Rep. 38, 3254–3264 (2017)

    Article  CAS  PubMed  Google Scholar 

  25. H.G. Kim, S.W. Jin, Y.A. Kim, T. Khanal, G.H. Lee, S.J. Kim, S. Dal Rhee, Y.C. Chung, Y.J. Hwang, T.C. Jeong, Leptin induces CREB-dependent aromatase activation through COX-2 expression in breast cancer cells. Food Chem. Toxicol. 106, 232–241 (2017)

    Article  CAS  PubMed  Google Scholar 

  26. M. Hosney, S. Sabet, M. El-Shinawi, K.M. Gaafar, M.M. Mohamed, Leptin is overexpressed in the tumor microenvironment of obese patients with estrogen receptor positive breast cancer. Exp. Ther. Med. 13, 2235–2246 (2017)

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  27. S.M. Louie, L.S. Roberts, D.K. Nomura, Mechanisms linking obesity and cancer. Biochim. Biophys. Acta Mol. Cell Biol. Lipids 1831, 1499–1508 (2013)

    Article  CAS  Google Scholar 

  28. C. Bjorbæk, B.B. Kahn, Leptin signaling in the central nervous system and the periphery. Recent Prog. Horm. Res. 59, 305–332 (2004)

    Article  PubMed  Google Scholar 

  29. D. Dutta, S. Ghosh, K. Pandit, P. Mukhopadhyay, S. Chowdhury, Leptin and cancer: Pathogenesis and modulation. Ind. J. Endocrin. Metabolism 16, S596 (2012)

    Article  CAS  Google Scholar 

  30. M.N. VanSaun, Molecular pathways: adiponectin and leptin signaling in cancer. Clin. Cancer Res. 19, 1926–1932 (2013)

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  31. N.K. Saxena, L. Taliaferro-Smith, B.B. Knight, D. Merlin, F.A. Anania, R.M. O'Regan, D. Sharma, Bidirectional crosstalk between leptin and insulin-like growth factor-I signaling promotes invasion and migration of breast cancer cells via transactivation of epidermal growth factor receptor. Cancer Res. 68, 9712–9722 (2008)

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  32. V.K. Clements, T. Long, R. Long, C. Figley, D. Smith, S. Ostrand-Rosenberg, Frontline Science: High fat diet and leptin promote tumor progression by inducing myeloid-derived suppressor cells. J. Leukoc. Biol. 103, 395–407 (2018)

    Article  CAS  PubMed  Google Scholar 

  33. T.N. Seyfried, L.C. Huysentruyt, On the origin of cancer metastasis. Crit. Rev. Oncog. 18, 43 (2013)

    Article  PubMed  PubMed Central  Google Scholar 

  34. A.W. Lambert, D.R. Pattabiraman, R.A. Weinberg, Emerging biological principles of metastasis. Cell 168, 670–691 (2017)

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  35. A. Voulgari, A. Pintzas, Epithelial–mesenchymal transition in cancer metastasis: mechanisms, markers and strategies to overcome drug resistance in the clinic. Biochim. Biophys. Acta Rev. Cancer 1796, 75–90 (2009)

  36. J.H. Tsai and J. Yang, Epithelial–mesenchymal plasticity in carcinoma metastasis. Genes Dev. 27, 2192–2206 (2013)

  37. M.J. Wheelock, Y. Shintani, M. Maeda, Y. Fukumoto, K.R. Johnson, Cadherin switching. J. Cell Sci. 121, 727–735 (2008)

  38. D.A. Lauffenburger, A.F. Horwitz, Cell migration: a physically integrated molecular process. Cell 84, 359–369 (1996)

  39. G. Bozzuto, P. Ruggieri, A. Molinari, Molecular aspects of tumor cell migration and invasion. Ann. Ist. Super. Sanita. 46, 66–80 (2010)

  40. T.D. Pollard, G.G. Borisy, Cellular motility driven by assembly and disassembly of actin filaments. Cell 112, 453–465 (2003)

  41. K. O'Connor, M. Chen, Dynamic functions of RhoA in tumor cell migration and invasion. Small GTPases 4, 141–147 (2013)

  42. B. Davidson, R. Reich, B. Risberg, J. Nesland, The biological role and regulation of matrix metalloproteinases (MMP) in cancer. Arkh. Patol. 64, 47–53 (2002)

  43. A.M. Weaver, Invadopodia: specialized cell structures for cancer invasion. Clin. Exp. 23, 97–105 (2006)

  44. M. Duffy, (Portland Press Limited, 2002),

  45. Y. Teng, J.L. Ross, J.K. Cowell, The involvement of JAK-STAT3 in cell motility, invasion, and metastasis. Jak-Stat. 3, e28086 (2014)

  46. B. Li, W.W. Xu, A.K.Y. Lam, Y. Wang, H.-F. Hu, X.Y. Guan, Y.R. Qin, N. Saremi, S.W. Tsao, Q.-Y. He, Significance of PI3K/AKT signaling pathway in metastasis of esophageal squamous cell carcinoma and its potential as a target for anti-metastasis therapy. Oncotarget 8, 38755 (2017)

  47. A.S. Dhillon, S. Hagan, O. Rath, W. Kolch, MAP kinase signalling pathways in cancer. Oncogene 26, 3279–3290 (2007)

  48. F. Seif, M. Khoshmirsafa, H. Aazami, M. Mohsenzadegan, G. Sedighi, M. Bahar, The role of JAK-STAT signaling pathway and its regulators in the fate of T helper cells. Cell Comm. Signal. 15, 23 (2017)

  49. P. Liu, H. Cheng, T.M. Roberts, J.J. Zhao, Targeting the phosphoinositide 3-kinase pathway in cancer. Nat. Rev. Drug Discov. 8, 627–644 (2009)

  50. K.L. Houseknecht, C.A. Baile, R.L. Matteri, M.E. Spurlock, The biology of leptin: a review. J. Anim. Sci. 76, 1405–1420 (1998)

  51. C.A. Siegrist-Kaiser, V. Pauli, C.E. Juge-Aubry, O. Boss, A. Pernin, W.W. Chin, I. Cusin, F. Rohner-Jeanrenaud, A.G. Burger, J. Zapf, Direct effects of leptin on brown and white adipose tissue. J. Clin. Invest. 100, 2858–2864 (1997)

  52. S. Blüher, C.S. Mantzoros, Leptin in humans: lessons from translational research. Am. J. Clin. Nutrition 89, 991S–997S (2009)

  53. S. Margetic, C. Gazzola, G. Pegg, R. Hill, Leptin: a review of its peripheral actions and interactions. Int. J. Obes. Relat. Metab. Disord. 26, 1407–1433 (2002)

  54. C.S. Mantzoros, The role of leptin in human obesity and disease: a review of current evidence. Ann. Intern. Med. 130, 671–680 (1999)

  55. H. Shimizu, Y. Shimomura, R. Hayashi, K. Ohtani, N. Sato, T. Futawatari, M. Mori, Serum leptin concentration is associated with total body fat mass, but not abdominal fat distribution. Int. J. Obes. Relat. Metab. Disord. 21, 536–541 (1997)

  56. R.V. Considine, M.K. Sinha, M.L. Heiman, A. Kriauciunas, T.W. Stephens, M.R. Nyce, J.P. Ohannesian, C.C. Marco, L.J. McKee, T.L. Bauer, Serum immunoreactive-leptin concentrations in normal-weight and obese humans. N. Engl. J. Med. 334, 292–295 (1996)

  57. J. Licinio, C. Mantzoros, A.B. Negrão, G. Cizza, M.-L. Wong, P.B. Bongiorno, G.P. Chrousos, B. Karp, C. Allen, J.S. Flier, Human leptin levels are pulsatile and inversely related to pituitary–ardenal function. Nat. Med. 3, 575–579 (1997)

  58. N.K. Saxena, D. Sharma, X. Ding, S. Lin, F. Marra, D. Merlin, F.A. Anania, Concomitant activation of the JAK/STAT, PI3K/AKT, and ERK signaling is involved in leptin-mediated promotion of invasion and migration of hepatocellular carcinoma cells. Cancer Res. 67, 2497–2507 (2007)

  59. Y. Ding, Y. Cao, B. Wang, L. Wang, Y. Zhang, D. Zhang, X. Chen, M. Li, C. Wang, APPL1-mediating leptin signaling contributes to proliferation and migration of cancer cells. PLoS ONE 11, e0166172 (2016)

  60. H. Feng, Q. Liu, N. Zhang, L. Zheng, M. Sang, J. Feng, J. Zhang, X. Wu, B. Shan, Leptin promotes metastasis by inducing an epithelial-mesenchymal transition in A549 lung cancer cells. Oncol. Res. 21, 165–171 (2014)

  61. A.L. Strong, J.F. Ohlstein, B.A. Biagas, L.V. Rhodes, D.T. Pei, H.A. Tucker, C. Llamas, A.C. Bowles, M.F. Dutreil, S. Zhang, Leptin produced by obese adipose stromal/stem cells enhances proliferation and metastasis of estrogen receptor positive breast cancers. Breast Cancer Res. 17, 112 (2015)

  62. S.D.H. Ahmed, F. Idrees, M. Ahsan, A. Khanam, N. Sultan, N. Akhter, Association of serum leptin with serum estradiol in relation to breast carcinogenesis: a comparative case-control study between pre-and postmenopausal women. Turkish J. Med. Sciences 48, 305–310 (2018)

  63. L.W. Bowers, E.L. Rossi, S.B. McDonell, S.S. Doerstling, S.A. Khatib, C.G. Lineberger, J.E. Albright, X. Tang, S.D. Hursting, Leptin signaling mediates obesity-associated CSC enrichment and EMT in preclinical TNBC models. Mol. Cancer Res. 16, 869–879 (2018)

  64. P.S. Thiagarajan, Q. Zheng, M. Bhagrath, E.E. Mulkearns-Hubert, M.G. Myers, J.D. Lathia, O. Reizes, STAT3 activation by leptin receptor is essential for TNBC stem cell maintenance. Endocr. Relat. Cancer 24, 415–426 (2017)

  65. H. Cao, Y. Huang, L. Wang, H. Wang, X. Pang, K. Li, W. Dang, H. Tang, L. Wei, M. Su, Leptin promotes migration and invasion of breast cancer cells by stimulating IL-8 production in M2 macrophages. Oncotarget 7, 65441 (2016)

  66. R. Price, D. Cavazos, R. De Angel, S. Hursting, Obesity-related systemic factors promote an invasive phenotype in prostate cancer cells. Prostate Cancer Prostatic Dis. 15, 135–143 (2012)

  67. K.-W. Yoon, S.-Y. Park, J.-Y. Kim, S.-M. Lee, C.H. Park, S.-B. Cho, W.-S. Lee, Y.-E. Joo, J.H. Lee, H.S. Kim, Leptin-induced adhesion and invasion in colorectal cancer cell lines. Oncol. Rep. 31, 2493–2498 (2014)

  68. J. Oba, W. Wei, J.E. Gershenwald, M.M. Johnson, C.M. Wyatt, J.A. Ellerhorst, E.A. Grimm, Elevated serum leptin levels are associated with an increased risk of sentinel lymph node metastasis in cutaneous melanoma. Medicine (Baltimore) 95, e3073 (2016)

  69. X. Wei, Y. Liu, C. Gong, T. Ji, X. Zhou, T. Zhang, D. Wan, S. Xu, P. Jin, X. Yang, Targeting leptin as a therapeutic strategy against ovarian cancer peritoneal metastasis. Anti-Cancer Agents in Medicinal Chemistry (Formerly Current Medicinal Chemistry-Anti-Cancer Agents). 17, 1093–1101 (2017)

  70. F. Campo-Verde-Arbocco, J.D. López-Laur, L.R. Romeo, N. Giorlando, F.A. Bruna, D.E. Contador, G. López-Fontana, F.E. Santiano, C.V. Sasso, L.E. Zyla, Human renal adipose tissue induces the invasion and progression of renal cell carcinoma. Oncotarget 8, 94223 (2017)

  71. Y. Huang, Q. Jin, M. Su, F. Ji, N. Wang, C. Zhong, Y. Jiang, Y. Liu, Z. Zhang, J. Yang, Leptin promotes the migration and invasion of breast cancer cells by upregulating ACAT2. Cell. Oncol. 40, 537–547 (2017)

  72. K. Li, L. Wei, Y. Huang, Y. Wu, M. Su, X. Pang, N. Wang, F. Ji, C. Zhong, T. Chen, Leptin promotes breast cancer cell migration and invasion via IL-18 expression and secretion. Int. J. Oncol. 48, 2479–2487 (2016)

  73. A. Meerson, H. Yehuda, Leptin and insulin up-regulate miR-4443 to suppress NCOA1 and TRAF4, and decrease the invasiveness of human colon cancer cells. BMC Cancer. 16, 882 (2016)

  74. I. Tourkantonis, M. Kiagia, E. Peponi, S. Tsagouli, K.N. Syrigos, The role of leptin in cancer pathogenesis. J. Cancer Ther. 4, 640 (2013)

  75. G. Newman, R.R. Gonzalez-Perez, Leptin–cytokine crosstalk in breast cancer. Mol. Cell. Endocrinol. 382, 570–582 (2014)

  76. L.A. Tartaglia, The leptin receptor. J. Biol. Chem. 272, 6093–6096 (1997)

  77. G. Frühbeck, Intracellular signalling pathways activated by leptin. Biochem. J. 393, 7–20 (2006)

  78. D. Shida, J. Kitayama, K. Mori, T. Watanabe, H. Nagawa, Transactivation of epidermal growth factor receptor is involved in leptin-induced activation of janus-activated kinase 2 and extracellular signal–regulated kinase 1/2 in human gastric cancer cells. Cancer Res. 65, 9159–9163 (2005)

  79. J.W. Park, C.R. Han, L. Zhao, M. Willingham, S.-y. Cheng, Inhibition of STAT3 activity delays obesity-induced thyroid carcinogenesis in a mouse model. Endocr. Relat. Cancer. ERC-15-0417 (2015)

  80. I. Haque, A. Ghosh, S. Acup, S. Banerjee, K. Dhar, A. Ray, S. Sarkar, S. Kambhampati, S.K. Banerjee, Leptin-induced ER-α-positive breast cancer cell viability and migration is mediated by suppressing CCN5-signaling via activating JAK/AKT/STAT-pathway. BMC Cancer 18, 99 (2018)

  81. J. Kumar, H. Fang, D.R. McCulloch, T. Crowley, A.C. Ward, Leptin receptor signaling via Janus kinase 2/Signal transducer and activator of transcription 3 impacts on ovarian cancer cell phenotypes. Oncotarget 8, 93530 (2017)

  82. H. Zahid, K. Subbaramaiah, N.M. Iyengar, X.K. Zhou, I.-C. Chen, P. Bhardwaj, A. Gucalp, M. Morrow, C.A. Hudis, A.J. Dannenberg, Leptin regulation of the p53-HIF1α/PKM2-aromatase axis in breast adipose stromal cells: a novel mechanism for the obesity–breast cancer link. Int. J. Obes. 42, 711 (2018)

  83. C. Giordano, F. Chemi, S. Panza, I. Barone, D. Bonofiglio, M. Lanzino, A. Cordella, A. Campana, A. Hashim, P. Rizza, Leptin as a mediator of tumor-stromal interactions promotes breast cancer stem cell activity. Oncotarget 7, 1262 (2016)

  84. S. Zhang, J. Jiang, Z. Chen, Y. Wang, W. Tang, C. Liu, L. Liu, Y. Chen, investigation of LEP and LEPR polymorphisms with the risk of hepatocellular carcinoma: a case–control study in eastern chinese han population. OncoTargets and Therapy 11, 2083 (2018)

  85. C.-R. Liu, Q. Li, C. Hou, H. Li, P. Shuai, M. Zhao, X.-R. Zhong, Z.-P. Xu, J.-Y. Li, Changes in body mass index, leptin, and leptin receptor polymorphisms and breast cancer risk. DNA Cell Biol. 37, 182–188 (2018)

  86. H. Qiu, X. Lin, W. Tang, C. Liu, Y. Chen, H. Ding, M. Kang, S. Chen, Investigation of TCF7L2, LEP and LEPR polymorphisms with esophageal squamous cell carcinomas. Oncotarget 8, 109107 (2017)

  87. J. Bieńkiewicz, H. Romanowicz, A. Malinowski, B. Smolarz, Association of single nucleotide polymorphism-2548 G/A (rs12112075) of leptin gene with endometrial cancer and uterine leiomyomas. Eur. J. Obstet. Gynecol. Reprod. Biol. 218, 113–118 (2017)

  88. H. Luan, H. Zhang, Y. Li, P. Wang, L. Cao, H. Ma, Q. Cui, G. Tian, Association of two obesity-related gene polymorphisms LEPG2548A rs7799039 and LEPRQ223R rs1137101 with the risk of breast cancer. Oncotarget 8, 59333 (2017)

  89. X. Yuan, Z. Xu, C. Liu, L. Yan, P. Tao, P. Xiong, Q. Li, M. Zhou, H. Li, M. Zhao, Study of the association between polymorphism of persistent obesity, human leptin gene/leptin receptor gene and molecular subtypes of breast cancer. Zhonghua yu fang yi xue za zhi (Chinese Journal of Preventive Medicine) 51, 533–538 (2017)

  90. T. Amer, R. El-Baz, A.-R. Mokhtar, S. El-Shaer, R. Elshazli and A. Settin, Genetic polymorphisms of IL-23R (rs7517847) and LEP (rs7799039) among Egyptian patients with hepatocellular carcinoma. Arch. Physiol. Biochem. 123, 279–285 (2017)

  91. M.A.-B. El-Hussiny, M.A. Atwa, W.E. Rashad, D.A. Shaheen, N.M. Elkady, Leptin receptor Q223R polymorphism in Egyptian female patients with breast cancer. Contemp. Oncol. 21, 42 (2017)

  92. A. Méndez-Hernández, M.P. Gallegos-Arreola, H. Moreno-Macías, J.E. Fematt, R. Pérez-Morales, LEP rs7799039, LEPR rs1137101, and ADIPOQ rs2241766 and 1501299 polymorphisms are associated with obesity and chemotherapy response in Mexican women with breast cancer. Clin. Breast Cancer 17, 453–462 (2017)

  93. C. Rodrigo, K.H. Tennekoon, E.H. Karunanayake, K. De Silva, I. Amarasinghe, A. Wijayasiri, Circulating leptin, soluble leptin receptor, free leptin index, visfatin and selected leptin and leptin receptor gene polymorphisms in sporadic breast cancer. Endocr. J. 64, 393–401 (2017)

  94. D.R. Farias, A.B. Franco-Sena, F. Rebelo, G.F. Salles, C.J. Struchiner, M.C. Martins, G. Kac, Polymorphisms of leptin (G2548A) and leptin receptor (Q223R and K109R) genes and blood pressure during pregnancy and the postpartum period: A Cohort. Am. J. Hypertens. 30, 130–140 (2017)

  95. A. Babic, Y. Bao, Z.R. Qian, C. Yuan, E.L. Giovannucci, H. Aschard, P. Kraft, L.T. Amundadottir, R.Z. Stolzenberg-Solomon, V. Morales-Oyarvide, Pancreatic cancer risks associated with prediagnostic plasma levels of leptin and leptin receptor genetic polymorphisms. Cancer Res. 1699, 7160–7167 (2016)

  96. T. Mahmoudi, H. Farahani, H. Nobakht, R. Dabiri, M.R. Zali, Genetic variations in leptin and leptin receptor and susceptibility to colorectal cancer and obesity. Iran J Cancer Prev. 9, e7013 (2016)

  97. P. Rodrigues, L. Maia, M. Santos, G. Peterle, L. Alves, J. Takamori, R. Souza, W. Barbosa, A. Mercante, F. Nunes, Leptin receptor expression and Gln223Arg polymorphism as prognostic markers in oral and oropharyngeal cancer. Genet. Mol. Res. 14, 14979–14988 (2015)

  98. A.M. Mendonsa, M.C. Chalfant, L.D. Gorden, M.N. VanSaun, Modulation of the leptin receptor mediates tumor growth and migration of pancreatic cancer cells. PLoS ONE 10, e0126686 (2015)

  99. M. Szyszka, M. Tyczewska, P. Milecka, K. Jopek, P. Celichowski, L.K. Malendowicz, M. Rucinski, Effects of leptin on leptin receptor isoform expression and proliferative activity in human normal prostate and prostate cancer cell lines. Oncol. Rep. 39, 182–192 (2018)

  100. R. Sultana, A.C. Kataki, B.B. Borthakur, T.K. Basumatary, S. Bose, Imbalance in leptin-adiponectin levels and leptin receptor expression as chief contributors to triple negative breast cancer progression in Northeast India. Gene. 621, 51–58 (2017)

  101. Y. Pan, F. Zhou, C. He, L. Hui, T. Huang, Y. Wei, Leptin-LepRb expressed in gastric cancer patients and related to cancer-related depression. Biomed. Res. Int. 2017, 1–7 (2017)

    Google Scholar 

  102. Y.-C. Lee, W.-J. Wu, H.-H. Lin, W.-M. Li, C.-N. Huang, W.-C. Hsu, L.-L. Chang, C.-C. Li, H.-C. Yeh, C.-F. Li, Prognostic value of leptin receptor overexpression in upper tract urothelial carcinomas in Taiwan. Clin. Genitourin. Cancer 15, e653–e659 (2017)

  103. H. Feng, P. Guo, J. Wang, Q. Liu, J. Xu, H. Yang, J. Zhang, Association of the expression of leptin and leptin receptor with bone metastasis in pulmonary adenocarcinoma. Zhonghua zhong liu za zhi (Chinese Journal of Oncology) 38, 840–844(2016)

  104. N. Saetang, T. Boonpipattanapong, A. Palanusont, W. Maneechay, S. Sangkhathat, Alteration of leptin and adiponectin in multistep colorectal tumorigenesis. Asian Pac. J. Cancer Prev. 17, 2119–2123 (2016)

  105. S. Kato, L. Abarzua-Catalan, C. Trigo, A. Delpiano, C. Sanhueza, K. García, C. Ibañez, K. Hormazábal, D. Diaz, J. Brañes, Leptin stimulates migration and invasion and maintains cancer stem-like properties in ovarian cancer cells: an explanation for poor outcomes in obese women. Oncotarget 6, 21100 (2015)

  106. S. Uddin, R. Bu, M. Ahmed, J. Abubaker, F. Al-Dayel, P. Bavi, K.S. Al-Kuraya, Overexpression of leptin receptor predicts an unfavorable outcome in Middle Eastern ovarian cancer. Mol. Cancer. 8, 74 (2009)

  107. Y. Fan, Y. Gan, Y. Shen, X. Cai, Y. Song, F. Zhao, M. Yao, J. Gu, H. Tu, Leptin signaling enhances cell invasion and promotes the metastasis of human pancreatic cancer via increasing MMP-13 production. Oncotarget 6, 16120 (2015)

  108. A. Horiguchi, M. Sumitomo, J. Asakuma, T. Asano, R. Zheng, T. Asano, D.M. Nanus, M. Hayakawa, Increased serum leptin levels and over expression of leptin receptors are associated with the invasion and progression of renal cell carcinoma. J. Urol. 176, 1631–1635 (2006)

  109. M. Ishikawa, J. Kitayama, H. Nagawa, Expression pattern of leptin and leptin receptor (OB-R) in human gastric cancer. World J. Gastroenterol. 12, 5517 (2006)

  110. N. Erkasap, M. Ozkurt, S. Erkasap, F. Yasar, K. Uzuner, E. Ihtiyar, S. Uslu, M. Kara, O. Bolluk, Leptin receptor (Ob-R) mRNA expression and serum leptin concentration in patients with colorectal and metastatic colorectal cancer. Braz. J. Med. Biol. Res. 46, 306–310 (2013)

  111. Y.L. Fan, X.Q. Li, Expression of leptin and its receptor in thyroid carcinoma: distinctive prognostic significance in different subtypes. Clin. Endocrinol. 83, 261–267 (2015)

  112. C. Garofalo, M. Koda, S. Cascio, M. Sulkowska, L. Kanczuga-Koda, J. Golaszewska, A. Russo, S. Sulkowski, E. Surmacz, Increased expression of leptin and the leptin receptor as a marker of breast cancer progression: possible role of obesity-related stimuli. Clin. Cancer Res. 12, 1447–1453 (2006)

  113. M. Ishikawa, J. Kitayama, H. Nagawa, Enhanced expression of leptin and leptin receptor (OB-R) in human breast cancer. Clin. Cancer Res. 10, 4325–4331 (2004)

  114. Y.-J. Xu, Y.-F. Shao, X. Zhao, Y.-T. Geng, K. Wang, Y.-M. Yin, Expression and clinical significance of leptin, the functional receptor of leptin (OB-Rb) and HER-2 in non-small-cell lung cancer: a retrospective analysis. J. Cancer Res. Clin. Oncol. 137, 1841 (2011)

  115. U.H. Frixen, J. Behrens, M. Sachs, G. Eberle, B. Voss, A. Warda, D. Löchner, W. Birchmeier, E-cadherin-mediated cell-cell adhesion prevents invasiveness of human carcinoma cells. J. Cell Biol. 113, 173–185 (1991)

  116. K. Strumane, G. Berx, F. Van Roy, in Cell adhesion, (Springer, 2004), p. 69–103

  117. F. Van Roy, G. Berx, The cell-cell adhesion molecule E-cadherin. Cell. Mol. Life Sci. 65, 3756–3788 (2008)

  118. B.M. Gumbiner, Regulation of cadherin-mediated adhesion in morphogenesis. Nat. Rev. Mol. Cell Biol. 6, 622–634 (2005)

  119. W. Shih, S. Yamada, N-cadherin as a key regulator of collective cell migration in a 3D environment. Cell Adh. Migr. 6, 513–517 (2012)

  120. W. Shih, S. Yamada, N-cadherin-mediated cell-cell adhesion promotes cell migration in a three-dimensional matrix. J. Cell Sci. 125, 3661–3670 (2012)

  121. S. Lamouille, J. Xu, R. Derynck, Molecular mechanisms of epithelial–mesenchymal transition. Nat. Rev. Mol. Cell Biol. 15, 178–196 (2014)

  122. A.K. Mishra, C.R. Parish, M.-L. Wong, J. Licinio, A.C. Blackburn, Leptin signals via TGFB1 to promote metastatic potential and stemness in breast cancer. PLoS ONE 12, e0178454 (2017)

  123. L. Wei, K. Li, X. Pang, B. Guo, M. Su, Y. Huang, N. Wang, F. Ji, C. Zhong, J. Yang, Leptin promotes epithelial-mesenchymal transition of breast cancer via the upregulation of pyruvate kinase M2. J. Exp. Clin. Cancer Res. 35, 166 (2016)

  124. L. Wang, C. Tang, H. Cao, K. Li, X. Pang, L. Zhong, W. Dang, H. Tang, Y. Huang, L. Wei, Activation of IL-8 via PI3K/Akt-dependent pathway is involved in leptin-mediated epithelial-mesenchymal transition in human breast cancer cells. Cancer Biol. Ther. 16, 1220–1230 (2015)

  125. D. Yan, D. Avtanski, N.K. Saxena, D. Sharma, Leptin-induced epithelial-mesenchymal transition in breast cancer cells requires β-catenin activation via Akt/GSK3-and MTA1/Wnt1 protein-dependent pathways. J. Biol. Chem. 287, 8598–8612 (2012)

  126. E. Trevellin, M. Scarpa, A. Carraro, F. Lunardi, A. Kotsafti, A. Porzionato, L. Saadeh, M. Cagol, R. Alfieri, U. Tedeschi, Esophageal adenocarcinoma and obesity: peritumoral adipose tissue plays a role in lymph node invasion. Oncotarget 6, 11203 (2015)

  127. K. Kushiro, N.P. Núñez, Ob/ob serum promotes a mesenchymal cell phenotype in B16BL6 melanoma cells. Clin. Exp. Metastasis 28, 877–886 (2011)

  128. Z. Wang, Y. Li, D. Kong, F. H Sarkar, The role of Notch signaling pathway in epithelial-mesenchymal transition (EMT) during development and tumor aggressiveness. Curr. Drug Targets 11, 745–751 (2010)

  129. Y. Li, J. Ma, X. Qian, Q. Wu, J. Xia, L. Miele, F. H Sarkar, Z. Wang, Regulation of EMT by Notch signaling pathway in tumor progression. Curr. Cancer Drug Targets 13, 957–962 (2013)

  130. A. Harbuzariu, R.R. Gonzalez-Perez, Leptin-Notch axis impairs 5-fluorouracil effects on pancreatic cancer. Oncotarget 9, 18239 (2018)

  131. M. Battle, C. Gillespie, A. Quarshie, V. Lanier, T. Harmon, K. Wilson, M. Torroella-Kouri, R.R. Gonzalez-Perez, Obesity induced a leptin-Notch signaling axis in breast cancer. Int. J. Cancer. 134, 1605–1616 (2014)

  132. C.C. Lipsey, A. Harbuzariu, D. Daley-Brown, R.R. Gonzalez-Perez, Oncogenic role of leptin and Notch interleukin-1 leptin crosstalk outcome in cancer. World J. Methodology 6, 43–55 (2016)

  133. A. Harbuzariu, G.M. Oprea-Ilies, R.R. Gonzalez-Perez, The role of notch signaling and leptin-notch crosstalk in pancreatic cancer. Medicines (Basel, Switzerland). 5, E68 (2018)

  134. A. Harbuzariu, A. Rampoldi, D.S. Daley-Brown, P. Candelaria, T.L. Harmon, C.C. Lipsey, D.J. Beech, A. Quarshie, G.O. Ilies, R.R. Gonzalez-Perez, Leptin-Notch signaling axis is involved in pancreatic cancer progression. Oncotarget 8, 7740 (2017)

  135. S. Guo, R.R. Gonzalez-Perez, Notch, IL-1 and leptin crosstalk outcome (NILCO) is critical for leptin-induced proliferation, migration and VEGF/VEGFR-2 expression in breast cancer. PLoS ONE 6, e21467 (2011)

  136. L.S. Colbert, K. Wilson, S. Kim, Y. Liu, G. Oprea-Ilies, C. Gillespie, T. Dickson, G. Newman, R.R. Gonzalez-Perez, NILCO biomarkers in breast cancer from Chinese patients. BMC Cancer 14, 249 (2014)

  137. C. Gillespie, A. Quarshie, M. Penichet, R. Gonzalez-Perez, Potential role of leptin signaling in DMBA-induced mammary tumors by non-responsive C57BL/6J mice fed a high-fat diet. J Carcinogene Mutagene 3, 20–23 (2012)

  138. D. Daley-Brown, G. Oprea-Iles, K.T. Vann, V. Lanier, R. Lee, P.V. Candelaria, A. Quarshie, R. Pattillo, R.R. Gonzalez-Perez, Type II endometrial Cancer overexpresses NILCO: A preliminary evaluation. Dis. Markers 2017, 1–14 (2017)

    Article  CAS  Google Scholar 

  139. A. Zaravinos, The regulatory role of microRNAs in EMT and cancer. J. Oncol. 2015, 1–13 (2015)

    Article  CAS  Google Scholar 

  140. J. Yu, K. Ohuchida, K. Mizumoto, N. Sato, T. Kayashima, H. Fujita, K. Nakata, M. Tanaka, MicroRNA, hsa-miR-200c, is an independent prognostic factor in pancreatic cancer and its upregulation inhibits pancreatic cancer invasion but increases cell proliferation. Mol. Cancer 9, 169 (2010)

  141. S. Brabletz, K. Bajdak, S. Meidhof, U. Burk, G. Niedermann, E. Firat, U. Wellner, A. Dimmler, G. Faller, J. Schubert, The ZEB1/miR-200 feedback loop controls Notch signalling in cancer cells. EMBO J. 30, 770–782 (2011)

  142. U. Burk, J. Schubert, U. Wellner, O. Schmalhofer, E. Vincan, S. Spaderna, T. Brabletz, A reciprocal repression between ZEB1 and members of the miR-200 family promotes EMT and invasion in cancer cells. EMBO Rep. 9, 582–589 (2008)

  143. C.C. Chang, M.J. Wu, J.Y. Yang, I. Carmarillo, C.-J. Chang, Leptin-STAT3-G9a signaling promotes obesity-mediated breast cancer progression. Cancer Res. 75, 2375–2386 (2015)

  144. C.I.T. Mantho, A. Harbuzariu, R.R. Gonzalez-Perez, Histone deacetylases, microRNA and leptin crosstalk in pancreatic cancer. World J. Clin. Oncol. 8, 178 (2017)

  145. J. Joseph-Silverstein, R.L. Silverstein, Cell adhesion molecules: an overview. Cancer Invest. 16, 176–182 (1998)

  146. B. Leitinger, E. Hohenester, Mammalian collagen receptors. Matrix Biol. 26, 146–155 (2007)

  147. P. Caswell, J. Norman, Endocytic transport of integrins during cell migration and invasion. Trends Cell Biol. 18, 257–263 (2008)

  148. E. Zamir, B. Geiger, Components of cell-matrix adhesions. J. Cell Sci. 114, 3577–3579 (2001)

  149. S.K. Mitra, D.A. Hanson, D.D. Schlaepfer, Focal adhesion kinase: in command and control of cell motility. Nat. Rev. Mol. Cell Biol. 6, 56–68 (2005)

  150. M.S. Diamond, D.E. Staunton, A.R. De Fougerolles, S.A. Stacker, J. Garcia-Aguilar, M.L. Hibbs, T.A. Springer, ICAM-1 (CD54): a counter-receptor for Mac-1 (CD11b/CD18). J. Cell Biol. 111, 3129–3139 (1990)

  151. N. Makrilia, A. Kollias, L. Manolopoulos, K. Syrigos, Cell adhesion molecules: role and clinical significance in cancer. Cancer Invest. 27, 1023–1037 (2009)

  152. Y. Maruo, A. Gochi, A. Kaihara, H. Shimamura, T. Yamada, N. Tanaka, K. Orita, ICAM-1 expression and the soluble ICAM-1 level for evaluating the metastatic potential of gastric cancer. Int. J. Cancer. 100, 486–490 (2002)

  153. A. Grothey, P. Heistermann, S. Philippou, R. Voigtmann, Serum levels of soluble intercellular adhesion molecule-1 (ICAM-1, CD54) in patients with non-small-cell lung cancer: correlation with histological expression of ICAM-1 and tumour stage. Br. J. Cancer 77, 801–807 (1998)

  154. P.-C. Chen, T.-H. Lin, H.-C. Cheng, C.-H. Tang, CCN3 increases cell motility and ICAM-1 expression in prostate cancer cells. Carcinogenesis 33, 937–945 (2012)

  155. A. Spina, F. Di Maiolo, A. Esposito, L. Sapio, E. Chiosi, L. Sorvillo, S. Naviglio, cAMP elevation down-regulates β 3 integrin and focal adhesion kinase and inhibits leptin-induced migration of MDA-MB-231 breast cancer cells. BioResearch 1, 324–332 (2012)

  156. S. Naviglio, D. Di Gesto, F. Illiano, E. Chiosi, A. Giordano, G. Illiano, A. Spina, Leptin potentiates antiproliferative action of cAMP elevation via protein kinase A down-regulation in breast cancer cells. J. Cell. Physiol. 225, 801–809 (2010)

  157. J. Ratke, F. Entschladen, B. Niggemann, K.S. Zänker, K. Lang, Leptin stimulates the migration of colon carcinoma cells by multiple signaling pathways. Endocr. Relat. Cancer. 17, 179–189 (2010)

  158. N.-M. Heida, M. Leifheit-Nestler, M.R. Schroeter, J.-P. Müller, I.-F. Cheng, S. Henkel, A. Limbourg, F.P. Limbourg, F. Alves, J.P. Quigley, Leptin enhances the potency of circulating angiogenic cells via src kinase and integrin αvβ5: implications for angiogenesis in human obesity. Arterioscler. Thromb. Vasc. Biol. 30, 200 (2010)

  159. S.-N. Yang, H.-T. Chen, H.-K. Tsou, C.-Y. Huang, W.-H. Yang, C.-M. Su, Y.-C. Fong, W.-P. Tseng, C.-H. Tang, Leptin enhances cell migration in human chondrosarcoma cells through OBRl leptin receptor. Carcinogenesis 30, 566–574 (2009)

  160. C.Y. Huang, H.S. Yu, T.Y. Lai, Y.L. Yeh, C.C. Su, H.H. Hsu, F.J. Tsai, C.H. Tsai, H.C. Wu, C.H. Tang, Leptin increases motility and integrin up-regulation in human prostate cancer cells. J. Cell. Physiol. 226, 1274–1282 (2011)

  161. C.K. Wong, P.F.Y. Cheung, C.W. Lam, Leptin-mediated cytokine release and migration of eosinophils: Implications for immunopathophysiology of allergic inflammation. Eur. J. Immunol. 37, 2337–2348 (2007)

  162. Z. Dong, S. Fu, X. Xu, Y. Yang, L. Du, W. Li, S. Kan, Z. Li, X. Zhang, L. Wang, Leptin-mediated regulation of ICAM-1 is Rho/ROCK dependent and enhances gastric cancer cell migration. Br. J. Cancer 110, 1801–1810 (2014)

  163. M. Suzukawa, R. Koketsu, S. Baba, S. Igarashi, H. Nagase, M. Yamaguchi, N. Matsutani, M. Kawamura, S. Shoji, A. Hebisawa, Leptin enhances ICAM-1 expression, induces migration and cytokine synthesis, and prolongs survival of human airway epithelial cells. Am. J. Physiol. Lung Cell. Mol. Physiol. 309, L801–L811 (2015)

  164. M. Yilmaz, G. Christofori, EMT, the cytoskeleton, and cancer cell invasion. Cancer Metastasis Rev. 28, 15–33 (2009)

  165. W.H. Goldmann, V. Auernheimer, I. Thievessen, B. Fabry, Vinculin, cell mechanics and tumour cell invasion. Cell Biol. Int. 37, 397–405 (2013)

  166. T. Li, H. Guo, Y. Song, X. Zhao, Y. Shi, Y. Lu, S. Hu, Y. Nie, D. Fan, K. Wu, Loss of vinculin and membrane-bound β-catenin promotes metastasis and predicts poor prognosis in colorectal cancer. Mol. Cancer. 13, 263 (2014)

  167. P. Friedl, K. Wolf, Tumour-cell invasion and migration: diversity and escape mechanisms. Nat. Rev. Cancer 3, 362–374 (2003)

  168. S.P. Palecek, J.C. Loftus, M.H. Ginsberg, D.A. Lauffenburger, A.F. Horwitz, Integrin-ligand binding properties govern cell migration speed through cell-substratum adhesiveness. Nature 385, 537 (1997)

  169. C. Ballestrem, B. Hinz, B.A. Imhof, B. Wehrle-Haller, Marching at the front and dragging behind. J. Cell Biol. 155, 1319–1332 (2001)

  170. C.D. Nobes, A. Hall, Rho, rac, and cdc42 GTPases regulate the assembly of multimolecular focal complexes associated with actin stress fibers, lamellipodia, and filopodia. Cell 81, 53–62 (1995)

  171. K. Wennerberg, C.J. Der, Rho-family GTPases: it's not only Rac and Rho (and I like it). J. Cell Sci. 117, 1301–1312 (2004)

  172. S. Narumiya, M. Tanji, T. Ishizaki, Rho signaling, ROCK and mDia1, in transformation, metastasis and invasion. Cancer Metastasis Rev. 28, 65–76 (2009)

  173. A.L. Bishop, H. Alan, Rho GTPases and their effector proteins. Biochem. J. 348, 241–255 (2000)

  174. A.J. Ridley, Rho GTPase signalling in cell migration. Curr. Opin. Cell Biol. 36, 103–112 (2015)

  175. A. Ghasemi, S.I. Hashemy, M. Aghaei, M. Panjehpour, RhoA/ROCK pathway mediates leptin-induced uPA expression to promote cell invasion in ovarian cancer cells. Cell. Signal. 32, 104–114 (2017)

  176. T. Jaffe, B. Schwartz, Leptin promotes motility and invasiveness in human colon cancer cells by activating multiple signal-transduction pathways. Int. J. Cancer. 123, 2543–2556 (2008)

  177. Y. Xie, C.M. Potter, A. Le Bras, W.N. Nowak, W. Gu, S.I. Bhaloo, Z. Zhang, Y. Hu, L. Zhang, Q. Xu, Leptin induces Sca-1+ progenitor cell migration enhancing neointimal lesions in vessel-injury mouse models. Arterioscler. Thromb. Vasc. Biol. 37, 2114–2127 (2017)

  178. Y.-E. Han, A. Lim, S.-H. Park, S. Chang, S.-H. Lee, W.-K. Ho, Rac-mediated actin remodeling and myosin II are involved in KATP channel trafficking in pancreatic β-cells. Exp. Mol. Med. 47, e190 (2015)

  179. Z. Li, J. Liang, W.K.K. Wu, X. Yu, J. Yu, X. Weng, J. Shen, Leptin activates RhoA/ROCK pathway to induce cytoskeleton remodeling in nucleus pulposus cells. Int. J. Mol. Sci. 15, 1176–1188 (2014)

  180. S.S. Stylli, A.H. Kaye, P. Lock, Invadopodia: at the cutting edge of tumour invasion. J. Clin. Neurosci. 15, 725–737 (2008)

  181. W.T. Chen, Proteolytic activity of specialized surface protrusions formed at rosette contact sites of transformed cells. J. Exp. Zool. A Ecol. Genet. Physiol. 251, 167–185 (1989)

  182. R.E. Vandenbroucke, C. Libert, Is there new hope for therapeutic matrix metalloproteinase inhibition? Nat. Rev. Drug Discov. 13, 904–927 (2014)

  183. A. Alaseem, K. Alhazzani, P. Dondapati, S. Alobid, A. Bishayee, A. Rathinavelu, in Semin. Cancer Biol., (Elsevier, 2017),

  184. Y. Gong, U.D. Chippada-Venkata, W.K. Oh, Roles of matrix metalloproteinases and their natural inhibitors in prostate cancer progression. Cancer 6, 1298–1327 (2014)

  185. L. Al-Alem, T.E. Curry, Ovarian cancer: involvement of the matrix metalloproteinases. Reproduction 150, R55–R64 (2015)

  186. J. Cathcart, A. Pulkoski-Gross , J. Cao, Targeting matrix metalloproteinases in cancer: bringing new life to old ideas. Genes Dis. 2, 26–34 (2015)

  187. S. Löffek, O. Schilling, C.-W. Franzke, (Eur Respiratory Soc, 2011),

  188. E.M. Sobrinho Santos, T.A. Guimaraes, H.O. Santos, L.M.B. Cangussu, S.F. de Jesus, C.A.d.C. Fraga, C.M. Cardoso, S.H.S. Santos, A.M.B. de Paula, R.S. Gomez, Leptin acts on neoplastic behavior and expression levels of genes related to hypoxia, angiogenesis, and invasiveness in oral squamous cell carcinoma. Tumor Biol. 39, 1010428317699130 (2017)

  189. M. Hoffmann, E. Fiedor, A. Ptak, 17β-Estradiol reverses leptin-inducing ovarian cancer cell migration by the PI3K/Akt signaling pathway. Reproductive Sciences 23, 1600–1608 (2016)

  190. Y.S. Jo, G.S.R. Lee, S.Y. Nam, S.J. Kim, Progesterone inhibits leptin-induced invasiveness of BeWo cells. Int. J.Med. Sci. 12, 773–779 (2015)

  191. G. Han, W. Zhao, L. Wang, Z. Yue, R. Zhao, Y. Li, X. Zhou, X. Hu, J. Liu, Leptin enhances the invasive ability of glioma stem-like cells depending on leptin receptor expression. Brain Res. 1543, 1–8 (2014)

  192. L. Wang, H. Cao, X. Pang, K. Li, W. Dang, H. Tang, T. Chen, The effect of leptin and its mechanisms on the migration and invasion of human breast cancer MCF-7 cells. Xi bao yu fen zi mian yi xue za zhi (Chinese Journal of Cellular and Molecular Immunology) 29, 1272–1276 (2013)

  193. Y. Cha, Y. Kang, A. Moon, HER2 induces expression of leptin in human breast epithelial cells. BMB Reports 45, 719–723 (2012)

  194. M.-C. Lin, F.-Y. Wang, Y.-H. Kuo, F.-Y. Tang, Cancer chemopreventive effects of lycopene: suppression of MMP-7 expression and cell invasion in human colon cancer cells. J. Agric. Food Chem. 59, 11304–11318 (2011)

  195. N. Stefanou, V. Papanikolaou, Y. Furukawa, Y. Nakamura, A. Tsezou, Leptin as a critical regulator of hepatocellular carcinoma development through modulation of human telomerase reverse transcriptase. BMC Cancer 10, 442 (2010)

  196. V. McMurtry, A.-M. Simeone, R. Nieves-Alicea, A.M. Tari, Leptin utilizes Jun N-terminal kinases to stimulate the invasion of MCF-7 breast cancer cells. Clin. Exp. 26, 197–204 (2009)

  197. N. Johansson, M. Ahonen, V.-M. Kähäri, Matrix metalloproteinases in tumor invasion. Cell. Mol. Life Sci. 57, 5–15 (2000)

  198. B. Bauvois, New facets of matrix metalloproteinases MMP-2 and MMP-9 as cell surface transducers: outside-in signaling and relationship to tumor progression. Biochim. Biophys. Acta Rev. Cancer 1825, 29–36 (2012)

  199. M. Björklund, E. Koivunen, Gelatinase-mediated migration and invasion of cancer cells. Biochim. Biophys. Acta Rev. Cancer 1755, 37–69 (2005)

  200. E.M.S. Santos, R.G. da Rocha, H.O. Santos, T.A. Guimarães, C.A. de Carvalho Fraga, L.H. da Silveira, P.R. Batista, P.S.L. de Oliveira, G.A. Melo, S.H. Santos, Gallic acid modulates phenotypic behavior and gene expression in oral squamous cell carcinoma cells by interfering with leptin pathway. Pathol. Res. Pract. 214, 30–37 (2018)

  201. H. Zou, Y. Liu, D. Wei, T. Wang, K. Wang, S. Huang, L. Liu, Y. Li, J. Ge, X. Li, Leptin promotes proliferation and metastasis of human gallbladder cancer through OB-Rb leptin receptor. Int. J. Oncol. 49, 197–206 (2016)

  202. J.-H. Ahn, Y.S. Choi, J.-H. Choi, Leptin promotes human endometriotic cell migration and invasion by up-regulating MMP-2 through the JAK2/STAT3 signaling pathway. MHR: Basic Sci. Reprod. Med. 21, 792–802 (2015)

  203. N. Borkakoti, Structural studies of matrix metalloproteinases. J. Mol. Med. 78, 261–268 (2000)

  204. H. Nagase, J.F. Woessner, Matrix metalloproteinases. J. Biol. Chem. 274, 21491–21494 (1999)

  205. T.E. Curry Jr, K.G. Osteen, The matrix metalloproteinase system: changes, regulation, and impact throughout the ovarian and uterine reproductive cycle. Endocr. Rev. 24, 428–465 (2003)

  206. J. Wang, X. Li, X. Gao, S. An, H. Liu, J. Liang, K. Zhang, Z. Liu, J. Wang, Z. Chen, Expression of MMP-13 is associated with invasion and metastasis of papillary thyroid carcinoma. Eur. Rev. Med. Pharmacol. Sci. 17, 427–435 (2013)

  207. B. Zhang, X. Cao, Y. Liu, W. Cao, F. Zhang, S. Zhang, H. Li, L. Ning, L. Fu, Y. Niu, Tumor-derived matrix metalloproteinase-13 (MMP-13) correlates with poor prognosis of invasive breast cancer. BMC Cancer 8, 83 (2008)

  208. B. Yang, J. Gao, Z. Rao, Q. Shen, Clinicopathological significance and prognostic value of MMP-13 expression in colorectal cancer. Scand. J. Clin. Lab. Invest. 72, 501–505 (2012)

  209. B. Hantke, N. Harbeck, B. Schmalfeldt, I. Claes, O. Hiller, M.-O. Luther, A. Welk, W. Kuhn, M. Schmitt, H. Tschesche, Clinical relevance of matrix metalloproteinase-13 determined with a new highly specific and sensitive ELISA in ascitic fluid of advanced ovarian carcinoma patients. Biol. Chem. 384, 1247–1251 (2003)

  210. W.L. Yeh, D.Y. Lu, M.J. Lee, W.M. Fu, Leptin induces migration and invasion of glioma cells through MMP-13 production. Glia 57, 454–464 (2009)

  211. D. Iliopoulos, K.N. Malizos, A. Tsezou, Epigenetic regulation of leptin affects MMP-13 expression in osteoarthritic chondrocytes: possible molecular target for osteoarthritis therapeutic intervention. Ann. Rheum. Dis. 66, 1616–1621 (2007)

  212. A. Koskinen, K. Vuolteenaho, R. Nieminen, T. Moilanen, E. Moilanen, Leptin enhances MMP-l, MMP-3 and MMP-13 production in human osteoarthritic cartilage and correlates with MMP-1 and MMP-3 in synovial fluid from OA patients. Clin. Exp. Rheumatol. 29, 57 (2011)

  213. R.C. Williams, A.J. Skelton, S.M. Todryk, A.D. Rowan, P.M. Preshaw, J.J. Taylor, Leptin and pro-inflammatory stimuli synergistically upregulate MMP-1 and MMP-3 secretion in human gingival fibroblasts. PLoS ONE 11, e0148024 (2016)

  214. L. Liberale, A. Bonaventura, F. Carbone, M. Bertolotto, P. Contini, N. Scopinaro, G.B. Camerini, F.S. Papadia, R. Cordera, G.G. Camici, Early reduction of matrix metalloproteinase-8 serum levels is associated with leptin drop and predicts diabetes remission after bariatric surgery. Int. J. Cardiol. 245, 257–262 (2017)

  215. F.q. Wang, J. So, S. Reierstad, D.A. Fishman, Matrilysin (MMP-7) promotes invasion of ovarian cancer cells by activation of progelatinase. Int. J. Cancer 114, 19–31 (2005)

  216. A. Ghasemi, S.I. Hashemy, M. Aghaei, M. Panjehpour, Leptin induces matrix metalloproteinase 7 expression to promote ovarian cancer cell invasion by activating ERK and JNK pathways. J. Cell. Biochem. 119, 2333–2344 (2018)

  217. M.-C. Lin, S.-Y. Tsai, F.-Y. Wang, F.-H. Liu, J.-N. Syu, F.-Y. Tang, Leptin induces cell invasion and the upregulation of matrilysin in human colon cancer cells. Biomedicine 3, 174–180 (2013)

  218. I. Yana, M. Seiki, MT-MMPs play pivotal roles in cancer dissemination. Clin. Exp. Metastasis 19, 209–215 (2002)

  219. Y. Itoh, Membrane-type matrix metalloproteinases: their functions and regulations. Matrix Biol. 44, 207–223 (2015)

  220. Z. Dong, X. Xu, L. Du, Y. Yang, H. Cheng, X. Zhang, Z. Li, L. Wang, J. Li, H. Liu, Leptin-mediated regulation of MT1-MMP localization is KIF1B dependent and enhances gastric cancer cell invasion. Carcinogenesis 34, 974–983 (2013)

  221. H. Wang, H. Cheng, Q. Shao, Z. Dong, Q. Xie, L. Zhao, Q. Wang, B. Kong, X. Qu, Leptin-promoted human extravillous trophoblast invasion is MMP14 dependent and requires the cross talk between Notch1 and PI3K/Akt signaling. Biol. Reprod. 90, 71–10 (2014)

  222. K. Dass, A. Ahmad, A.S. Azmi, S.H. Sarkar, F.H. Sarkar, Evolving role of uPA/uPAR system in human cancers. Cancer Treat. Rev. 34, 122–136 (2008)

  223. C.E. de Bock, Y. Wang, Clinical significance of urokinase-type plasminogen activator receptor (uPAR) expression in cancer. Med. Res. Rev. 24, 13–39 (2004)

  224. P.A. van Dam, A. Coelho, C. Rolfo, Is there a role for urokinase-type plasminogen activator inhibitors as maintenance therapy in patients with ovarian cancer? Eur. J. Surg. Oncol. 43, 252–257 (2017)

  225. P. Singh, T.E. Peterson, K.R. Barber, F.S. Kuniyoshi, A. Jensen, M. Hoffmann, A.S. Shamsuzzaman, V.K. Somers, Leptin upregulates the expression of plasminogen activator inhibitor-1 in human vascular endothelial cells. Biochem. Biophys. Res. Commun. 392, 47–52. (2010)

  226. S. Landskroner-Eiger, B. Qian, E.S. Muise, A.R. Nawrocki, J.P. Berger, E.J. Fine, W. Koba, Y. Deng, J.W. Pollard, P.E. Scherer, Proangiogenic contribution of adiponectin toward mammary tumor growth in vivo. Clin. Cancer Res. 15, 3265–3276 (2009)

  227. F. Messaggio, A.M. Mendonsa, J. Castellanos, N.S. Nagathihalli, L. Gorden, N.B. Merchant, M.N. VanSaun, Adiponectin receptor agonists inhibit leptin induced pSTAT3 and in vivo pancreatic tumor growth. Oncotarget 8, 85378 (2017)

  228. W. An, Y. Bai, S.-X. Deng, J. Gao, Q.-W. Ben, Q.-C. Cai, H.-G. Zhang, Z.-S. Li, Adiponectin levels in patients with colorectal cancer and adenoma: a meta-analysis. Eur. J. Cancer Prev. 21, 126–133 (2012)

  229. E. Petridou, C. Mantzoros, N. Dessypris, P. Koukoulomatis, C. Addy, Z. Voulgaris, G. Chrousos, D. Trichopoulos, Plasma adiponectin concentrations in relation to endometrial cancer: a case-control study in Greece. J. Clin. Endocrinol. Metab. 88, 993–997 (2003)

  230. P.C. Konturek, G. Burnat, T. Rau, E.G. Hahn, S. Konturek, Effect of adiponectin and ghrelin on apoptosis of Barrett adenocarcinoma cell line. Dig. Dis. Sci. 53, 597–605 (2008)

  231. S.S. Tworoger, A.H. Eliassen, T. Kelesidis, G.A. Colditz, W.C. Willett, C.S. Mantzoros, S.E. Hankinson, Plasma adiponectin concentrations and risk of incident breast cancer. J. Clin. Endocrinol. Metab. 92, 1510–1516 (2007)

  232. J.A. Handy, N.K. Saxena, P. Fu, S. Lin, J.E. Mells, N.A. Gupta, F.A. Anania, Adiponectin activation of AMPK disrupts leptin-mediated hepatic fibrosis via suppressors of cytokine signaling (SOCS-3). J. Cell. Biochem. 110, 1195–1207 (2010)

  233. I.L. Beales, C. Garcia-Morales, O.O. Ogunwobi, G. Mutungi, Adiponectin inhibits leptin-induced oncogenic signalling in oesophageal cancer cells by activation of PTP1B. Mol. Cell. Endocrinol. 382, 150–158 (2014)

  234. L. Lessard, M. Stuible, M.L. Tremblay, The two faces of PTP1B in cancer. Biochimica et Biophysica Acta (BBA)-Proteins and Proteomics 1804, 613–619 (2010)

  235. Z.-Y. Zhang, G.T. Dodd, T. Tiganis, Protein tyrosine phosphatases in hypothalamic insulin and leptin signaling. Trends Pharmacol. Sci. 36, 661–674 (2015)

  236. L. Taliaferro-Smith, A. Nagalingam, B.B. Knight, E. Oberlick, N.K. Saxena, D. Sharma, Integral role of PTP1B in adiponectin-mediated inhibition of oncogenic actions of leptin in breast carcinogenesis. Neoplasia 15, 23IN10–38IN11 (2013)

  237. D. Sharma, J. Wang, P.P. Fu, S. Sharma, A. Nagalingam, J. Mells, J. Handy, A.J. Page, C. Cohen, F.A. Anania, Adiponectin antagonizes the oncogenic actions of leptin in hepatocellular carcinogenesis. Hepatology 52, 1713–1722 (2010)

  238. X. Wu, Q. Yan, Z. Zhang, G. Du, X. Wan, Acrp30 inhibits leptin-induced metastasis by downregulating the JAK/STAT3 pathway via AMPK activation in aggressive SPEC-2 endometrial cancer cells. Oncol. Rep. 27, 1488–1496 (2012)

  239. S.A. Verploegen, G. Plaetinck, R. Devos, J. Van der Heyden, Y. Guisez, A human leptin mutant induces weight gain in normal mice. FEBS Lett 405, 237–240 (1997)

  240. L. Brunner, S. Whitebread, I. Leconte, A. Stricker-Krongrad, F. Cumin, M. Chiesi, N. Levens, A peptide leptin antagonist reduces food intake in rodents. Int. J. Obes. Relat. Metab. Disord. 23, 463–469 (1999)

  241. F. Peelman, K. Van Beneden, L. Zabeau, H. Iserentant, P. Ulrichts, D. Defeau, A. Verhee, D. Catteeuw, D. Elewaut, J. Tavernier, Mapping of the leptin binding sites and design of a leptin antagonist. J. Biol. Chem. 279, 41038–41046 (2004)

  242. H. Park, S.-H. Ahn, Y. Jung, J.C. Yoon, Y.-H. Choi, Leptin suppresses glutamate-induced apoptosis through regulation of ERK1/2 signaling pathways in rat primary astrocytes. Cell. Physiol. Biochem. 44, 2117–2128 (2017)

  243. G. Salomon, L. Niv-Spector, E.E. Gussakovsky, A. Gertler, Large-scale preparation of biologically active mouse and rat leptins and their L39A/D40A/F41A muteins which act as potent antagonists. Protein Expr. Purif. 47, 128–136 (2006)

  244. L. Niv-Spector, D. Gonen-Berger, I. Gourdou, E. Biener, E.E. Gussakovsky, Y. Benomar, K.V. Ramanujan, M. Taouis, B. Herman, I. Callebaut, Identification of the hydrophobic strand in the A–B loop of leptin as major binding site III: implications for large-scale preparation of potent recombinant human and ovine leptin antagonists. Biochem. J. 391, 221–230 (2005)

  245. S. Samuel-Mendelsohn, M. Inbar, E. Weiss-Messer, L. Niv-Spector, A. Gertler, R.J. Barkey, Leptin signaling and apoptotic effects in human prostate cancer cell lines. The Prostate 71, 929–945 (2011)

  246. S. Catalano, A. Leggio, I. Barone, R. De Marco, L. Gelsomino, A. Campana, R. Malivindi, S. Panza, C. Giordano, A. Liguori, A novel leptin antagonist peptide inhibits breast cancer growth in vitro and in vivo. J. Cell. Mol. Med. 19, 1122–1132 (2015)

  247. E. Fiedor, E.Ł. Gregoraszczuk, The molecular mechanism of action of superactive human leptin antagonist (SHLA) and quadruple leptin mutein Lan-2 on human ovarian epithelial cell lines. Cancer Chemother. Pharmacol. 78, 611–622 (2016)

  248. E. Fiedor, E. Gregoraszczuk, Superactive human leptin antagonist (SHLA), triple Lan1 and quadruple Lan2 leptin mutein as a promising treatment for human folliculoma. Cancer Chemother. Pharmacol. 80, 815–827 (2017)

  249. L. Niv-Spector, M. Shpilman, Y. Boisclair, A. Gertler, Large-scale preparation and characterization of non-pegylated and pegylated superactive ovine leptin antagonist. Protein Expr. Purif. 81, 186–192 (2012)

  250. M. Shpilman, L. Niv-Spector, M. Katz, C. Varol, G. Solomon, M. Ayalon-Soffer, E. Boder, Z. Halpern, E. Elinav, A. Gertler, Development and characterization of high affinity leptins and leptin antagonists. J. Biol. Chem. 286, 4429–4442 (2011)

  251. G. Bain, E. Collie-Duguid, G.I. Murray, F. Gilbert, A. Denison, F. McKiddie, T. Ahearn, I. Fleming, J. Leeds, P. Phull, Tumour expression of leptin is associated with chemotherapy resistance and therapy-independent prognosis in gastro-oesophageal adenocarcinomas. Br. J. Cancer. 110, 1525 (2014)

  252. E. Fiedor, K. Zajda, E.L. Gregoraszczuk, leptin receptor antagonists' action on HDAC expression eliminating the negative effects of leptin in ovarian cancer. Cancer Genomics Proteomics 15, 329–336 (2018)

  253. P. Grasso, M.C. Leinung, S.P. Ingher, D.W. Lee, In vivo effects of leptin-related synthetic peptides on body weight and food intake in female ob/ob mice: localization of leptin activity to domains between amino acid residues 106–140. Endocrinology. 138, 1413–1418 (1997)

  254. R.R. Gonzalez, P.C. Leavis, A peptide derived from the human leptin molecule is a potent inhibitor of the leptin receptor function in rabbit endometrial cells. Endocrine 21, 185–195 (2003)

  255. M. Ramos, B. Rueda, P. Leavis, R. Gonzalez, Leptin serves as an upstream activator of an obligatory signaling cascade in the embryo-implantation process. Endocrinology 146, 694–701 (2005)

  256. A. Leggio, S. Catalano, R. De Marco, I. Barone, S. Andò, A. Liguori, Therapeutic potential of leptin receptor modulators. Eur. J. Med. Chem. 78, 97–105 (2014)

  257. L. Otvos, E. Surmacz, Targeting the leptin receptor: a potential new mode of treatment for breast cancer. Expert Rev. Anticancer Ther. 11, 1147–1150 (2011)

  258. L. Otvos, I. Kovalszky, M. Riolfi, R. Ferla, J. Olah, A. Sztodola, K. Nama, A. Molino, Q. Piubello, J.D. Wade, Efficacy of a leptin receptor antagonist peptide in a mouse model of triple-negative breast cancer. Eur. J. Cancer 47, 1578–1584 (2011)

  259. S. Beccari, I. Kovalszky, J.D. Wade, L. Otvos Jr, E. Surmacz, Designer peptide antagonist of the leptin receptor with peripheral antineoplastic activity. Peptides 44, 127–134 (2013)

  260. T. Harmon, A. Harbuzariu, V. Lanier, C.C. Lipsey, W. Kirlin, L. Yang, R.R. Gonzalez-Perez, Nanoparticle-linked antagonist for leptin signaling inhibition in breast cancer. World J. Clin. Oncol. 8, 54 (2017)

  261. Y.-T. Chin, L.-M. Wang, M.-T. Hsieh, Y.-J. Shih, A.W. Nana, C.A. Changou, Y.-C.S. Yang, H.-C. Chiu, E. Fu, P.J. Davis, Leptin OB3 peptide suppresses leptin-induced signaling and progression in ovarian cancer cells. J. Biomed. Sci. 24, 51 (2017)

  262. Y.-C.S. Yang, Y.-T. Chin, M.-T. Hsieh, H.-Y. Lai, C.-C. Ke, D.R. Crawford, O.K. Lee, E. Fu, S.A. Mousa, P. Grasso, Novel leptin OB3 peptide-induced signaling and progression in thyroid cancers: comparison with leptin. Oncotarget 7, 27641 (2016)

  263. S.-H. Kim, A. Nagalingam, N.K. Saxena, S.V. Singh, D. Sharma, Benzyl isothiocyanate inhibits oncogenic actions of leptin in human breast cancer cells by suppressing activation of signal transducer and activator of transcription 3. Carcinogenesis 32, 359–367 (2010)

  264. M. Higginbottom, A.V.-A. Horgan, J. Horton, I. Simpson, C. Tyzack, (Google Patents, 2009),

  265. M. Fazeli, H. Zarkesh-Esfahani, Z. Wu, M. Maamra, M. Bidlingmaier, A.G. Pockley, P. Watson, G. Matarese, C.J. Strasburger, R.J. Ross, Identification of a monoclonal antibody against the leptin receptor that acts as an antagonist and blocks human monocyte and T cell activation. J. Immunol. Methods. 312, 190–200 (2006)

  266. L. Zabeau, A. Verhee, D. Catteeuw, L. Faes, S. Seeuws, T. Decruy, D. Elewaut, F. Peelman, J. Tavernier, Selection of non-competitive leptin antagonists using a random nanobody-based approach. Biochem. J. 441, 425–434 (2012)

Download references

Author information

Authors and Affiliations

  1. Department of Basic Medical Sciences, Neyshabur University of Medical Sciences, Neyshabur, Iran

    Ahmad Ghasemi & Mohsen Azimi-Nejad

  2. Department of Clinical Biochemistry, School of Pharmacy and Pharmaceutical Sciences, Isfahan University of Medical Sciences, Isfahan, Iran

    Ahmad Ghasemi

  3. Department of Physiology, School of Basic Science, Neyshabur Branch, Islamic Azad University, Neyshabur, Iran

    Jafar Saeidi

  4. Department of Genetic, School of Medicine, Mashhad University of Medical Sciences, Mashhad, Iran

    Mohsen Azimi-Nejad

  5. Surgical Oncology Research Center, Mashhad University of Medical Sciences, Mashhad, Iran

    Seyed Isaac Hashemy

Authors
  1. Ahmad Ghasemi
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Jafar Saeidi
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Mohsen Azimi-Nejad
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Seyed Isaac Hashemy
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Seyed Isaac Hashemy.

Ethics declarations

Conflict of interest

The authors declare that they have no conflict of interest.

Additional information

Publisher’s note

Springer Nature remains neutral with regard to jurisdiction-al claims in published maps and institutional affiliations.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Ghasemi, A., Saeidi, J., Azimi-Nejad, M. et al. Leptin-induced signaling pathways in cancer cell migration and invasion. Cell Oncol. 42, 243–260 (2019). https://doi.org/10.1007/s13402-019-00428-0

Download citation

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s13402-019-00428-0

Keywords

Search

Navigation